Serum Dkk-3 is also a potential biomarker for tissue fibrosis for lymphatic nephritis associated with systemic lupus erythematous disease (SLE) [103], and increased urinary Dkk-3 can identify patients with chronic kidney disease who are at risk for loss of kidney function [104]. This evidence concerns the gene DKK3 and chronic kidney disease.